Literature DB >> 25975995

Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib.

Umit Yavuz Malkan, Gursel Gunes, Sezgin Etgul, Tuncay Aslan, Seda Balaban, Ibrahim C Haznedaroglu.   

Abstract

Entities:  

Year:  2015        PMID: 25975995     DOI: 10.1177/1060028015579425

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  2 in total

1.  Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia.

Authors:  Andrew Stevenson Joel Chandranesan; Samip Master; Olivia Antosz; Breanne PeytonThomas; Nebu Koshy
Journal:  Case Rep Hematol       Date:  2018-05-06

2.  Rhabdomyolysis due to Trimethoprim-Sulfamethoxazole Administration following a Hematopoietic Stem Cell Transplant.

Authors:  Alexander Augustyn; Mona Lisa Alattar; Harris Naina
Journal:  Case Rep Oncol Med       Date:  2015-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.